4D-110
4D-110-CP-0001
Phase 1 mab active
Quick answer
4D-110 for Choroideremia is a Phase 1 program (mab) at 4D Molecular Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- 4D Molecular Therapeutics
- Indication
- Choroideremia
- Phase
- Phase 1
- Modality
- mab
- Status
- active